Insulin resistance in Hispanic large-for-gestational-age neonates at birth

Jennifer Shine Dyer1, Charles R Rosenfeld, Julie Rice

  • 1Department of Pediatrics, Division of Endocrinology, The Ohio State University, 700 Children's Drive, W322, Columbus, Ohio 43205, USA. dyerj@pediatrics.ohio-state.edu

Insights

Reduced insulin sensitivity is present at birth in large Hispanic newborns, indicating insulin resistance may begin before birth. This suggests altered fetal programming in response to maternal diabetes or large size.

Area of Science:

  • Perinatology
  • Neonatal Metabolism
  • Endocrinology

Background:

  • Maternal diabetes and macrosomia are known risk factors for insulin resistance and metabolic syndrome.
  • Hispanic youth exhibit high metabolic syndrome prevalence, but neonatal metabolic status is unclear.
  • This study investigates early metabolic changes in at-risk Hispanic neonates.

Purpose of the Study:

  • To determine if insulin sensitivity abnormalities exist at or shortly after birth in large-for-gestational-age (LGA) neonates born to Hispanic women.
  • To compare insulin sensitivity in LGA neonates born to mothers with and without gestational diabetes.
  • To assess if early signs of insulin resistance are present in utero.

Main Methods:

  • Cross-sectional study of 42 term Hispanic neonates within 48 hours of birth.
  • Groups included LGA neonates of mothers with gestational diabetes (LGA-IDM), LGA neonates of mothers without gestational diabetes (LGA-non-IDM), small-for-gestational-age, and appropriate-for-gestational-age controls.
  • Insulin sensitivity and secretion were measured using a shortened fasting intravenous glucose tolerance test.

Main Results:

  • All neonates were euglycemic at the time of study.
  • Insulin sensitivity was significantly lower in LGA-IDM and LGA-non-IDM neonates compared to controls.
  • No significant differences in insulin secretion were observed between the groups.

Conclusions:

  • Reduced insulin sensitivity is evident shortly after birth in Hispanic LGA neonates, regardless of maternal gestational diabetes status.
  • This suggests the onset of insulin resistance occurs before birth.
  • Findings indicate altered fetal programming contributing to metabolic abnormalities.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...